KCI, otherwise known as Kinetic Concepts, Inc., is a medical technology company that is globally leading the field. The mission of the company is to discover, develop, manufacture, and market the best innovative, technologically advanced therapies and products for wound care, tissue regeneration and therapeutic support systems.
They are headquartered in San Antonio, Texas, span more than 30 years and is historically known to have deep roots in the field of accelerated wound healing. Advanced wound care (V.A.C. therapy) is one of their growing business models. V.A.C. therapy (vacuum assisted closure) has been clinically proven to increase wound healing through unique equipments and methods while decreasing the overhead expense of treating patients with complex wounds.
There have been many studies on the benefits and results of V.A.C. therapy. Two of the studies were presented at the 22nd Symposium on Advanced Wound Care/Wound Healing Society Meeting in Dallas, Texas. Two studies were accepted for oral presentation, with one ranking third among the top three selected for oral presentation at the symposium.
V.A.C. vs. AMWT (Advanced Moist Wound Therapy)
This study, reporting the healthcare utilization, hospitalization and surgical procedure cost differences between the use of KCI’s proprietary V.A.C. Therapy versus Advanced Moist Wound Therapy (AMWT) in patients with diabetic foot ulcers (DFUs), will be presented by Vickie R. Driver, DPM, MS, FACFAS.
Dr. Driver analyzed the data from a multi-center, 342-patient randomized clinical trial (RCT) that assessed the efficacy and safety of negative wound pressure therapy using reticulated open cell foam (NPWT/ROCF) as delivered by V.A.C. Therapy comparatively to AMWT in adult patients with diabetic foot ulcers.
“The study found that during the active treatment phase [112 days] of the RCT, patients with DFUs treated with V.A.C. Therapy had fewer hospital admissions and amputations,” said Dr. Driver. “This resulted in lower costs related to hospitalizations and surgical procedures compared to patients treated with AMWT.”
An additional abstract on NPWT using V.A.C. Therapy was selected for oral presentation. Michael N. Desvigne, M.D., FACS will present “Early Intervention Using Negative Pressure Wound Therapy: Does It Make a Difference in Compartment Syndrome?” This retrospective review of 8 patients indicated that early initiation of V.A.C. Therapy in study patients with compartment syndrome requiring fasciotomy may enhance limb salvage by reducing edema and promoting perfusion.
Nine posters reporting the results of studies evaluating the use of KCI’s proprietary V.A.C. Therapy system to bolster split thickness skin grafts and to treat pressure ulcers, diabetic foot ulcers and other wounds will also be presented at SAWC. They consist of the following:
• Improving Split Thickness Skin Graft Take with V.A.C. Therapy
• Staged Surgical Closure in Combination with V.A.C. Therapy Increases Closure Success of Stage III and IV Pressure Ulcers
• Pediatric Wounds on the Foot Respond Favorably to V.A.C. Therapy
• Negative Pressure Wound Therapy in the Management of Diabetic Foot Ulcers for Managed Care Patients
• Effectiveness of V.A.C. Therapy in the Management of the Traumatic Open Abdomen
• Use of V.A.C. Therapy for Delayed Primary Closure of Fasciotomy Wounds: A Retrospective Review
• Early Intervention Using V.A.C. Therapy: Does It Make a Difference in Necrotizing Soft Tissue Infection
• Early Use of V.A.C. Therapy in the Open Abdomen: Improved Outcomes with Reduced Times to Closure and Reduced Complications
• Early Intervention Using V.A.C. Therapy: Does It Make a Difference in Surgical Wounds?
“The data that will be presented at the Symposium on Advanced Wound Care adds to the extensive body of evidence supporting the clinical benefits of V.A.C. Therapy in treating the most serious wounds,” said Dr. Gilles Delecoeuillerie, Vice President of Global Medical Affairs and Clinical Sciences for KCI. “As a global leader in advanced wound care, KCI encourages research that complements the already impressive amount of scientific knowledge on V.A.C. Therapy.”